Research Focuses on New Drug Targets for Regenerative MS Therapies

Article

In a groundbreaking new study, researchers have identified a molecular pathway for stimulating the regeneration of new myelinating cells, and repairing the damage of debilitating neurological diseases.

In a groundbreaking new study, researchers have identified a molecular pathway for stimulating the regeneration of new myelinating cells, and repairing the damage of debilitating neurological diseases. According to a study authors, the findings could pave the way for potential new regenerative therapy candidates for neurological conditions, such as multiple sclerosis (MS).

The degeneration of myelin—the protective covering that surrounds nerve cells in the brain and spinal cord—causes disease progression in MS. Previous research has identified several small molecules that promote myelin repair in mice by enhancing the conversion of a type of stem cell called oligodendrocyte progenitor cells (OPCs) to oligodendrocytes.

“Many labs, including at Case Western Reserve, had identified drug candidates that kickstart the formation of new myelin, but exactly how each of these molecules affected brain cell function wasn’t clear,” study author Drew Adams, PhD, professor of novel therapeutics and assistant professor of genetics and genome sciences at Case Western Reserve University School of Medicine, said in a press release.

In the study, researchers from Case Western Reserve University found that many of the previously identified molecules trigger myelin regeneration by blocking specific enzymes, known as CYP51, TM7SF2, or EBP, which are used by brain cells to produce cholesterol.

Miconazole, a drug typically used to treat athlete’s foot, enhances myelin formation by inhibiting these cholesterol-producing enzymes, according to the study. The team found 20 additional therapies that also enhance myelin formation in this way. The researchers were able to pinpoint which enzymes were being blocked by which drugs from the accumulation of metabolites in the cholesterol pathway.

To read the full article, visit SpecialtyPharmacyTimes.com.

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit:  Chanintorn.v | stock.adobe.com - PTSD Mental health concept, Psychologist sitting and touch hand young depressed asian man for encouragement near window with low light environment.Selective focus.
Image credit:  JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Image credit: сергей костюченко | stock.adobe.com - human head with brain
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.